Literature DB >> 26577535

Age-Specific Regulation of Drug-Processing Genes in Mouse Liver by Ligands of Xenobiotic-Sensing Transcription Factors.

Cindy Yanfei Li1, Helen J Renaud1, Curtis D Klaassen1, Julia Yue Cui2.   

Abstract

The xenobiotic-sensing transcription factors (xeno-sensors) AhR, CAR, and PXR upregulate the expression of many drug-processing genes (DPGs) in liver. Previous studies have unveiled profound changes in the basal expression of DPGs during development; however, knowledge on the ontogeny of the inducibility of DPGs in response to pharmacological activation of xeno-sensors is still limited. The goal of this study was to investigate the age-specific regulation of DPGs by prototypical xeno-sensor ligands: 2,3,7,8-tetrachlorodibenzodioxin (TCDD) for AhR; 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) for CAR; and pregnane-16α-carbonitrile (PCN) for PXR during mouse liver development. The basal mRNAs of most DPGs were low during neonatal age, but gradually increased to adult levels, whereas some DPGs (Cyp1a2, Cyp2b10, Cyp3a11, Gstm2, Gstm3, Papss2, and Oatp1a4) exhibited an adolescent-predominant expression pattern. The inducibility of DPGs was age-specific: 1) during neonatal age, the highest fold increase in the mRNA expression was observed for Cyp1a2, Sult5a1, and Ugt1a9 by TCDD; Cyp3a11 and Mrp2 by TCPOBOP; as well as Gstm2 and Gstm3 by PCN; 2) during adolescent age, the highest fold increase in the mRNA expression was observed for Ugt1a6 and Mrp4 by TCDD, Cyp2b10, Ugt2b34, and Ugt2b35 by TCPOBOP, as well as Gsta1, Gsta4, Sult1e1, Ugt1a1, Mrp3, and Mrp4 by PCN; 3) in adults, the highest fold increase in the mRNA expression was observed for Aldh1a1, Aldh1a7, and Ugt2b36 by TCPOBOP, as well as Papss2 and Oatp1a4 by PCN. In conclusion, the inducibility of hepatic DPGs following the pharmacological activation of xeno-sensors is age specific.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26577535      PMCID: PMC4931882          DOI: 10.1124/dmd.115.066639

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  46 in total

1.  The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.

Authors:  P Wei; J Zhang; M Egan-Hafley; S Liang; D D Moore
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

Review 2.  Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity.

Authors:  Frank J Gonzalez; Zhong-Ze Fang; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-04-02       Impact factor: 4.481

3.  Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice.

Authors:  Julia Yue Cui; Helen J Renaud; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-03-23       Impact factor: 3.922

4.  RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development.

Authors:  Lai Peng; Byunggil Yoo; Sumedha S Gunewardena; Hong Lu; Curtis D Klaassen; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2012-03-20       Impact factor: 3.922

Review 5.  CYP induction-mediated drug interactions: in vitro assessment and clinical implications.

Authors:  Jiunn H Lin
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

Review 6.  Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion.

Authors:  J Whysner; P M Ross; G M Williams
Journal:  Pharmacol Ther       Date:  1996       Impact factor: 12.310

7.  Age-development and inducibility of hepatic glutathione S-transferase activities in mice, rats, rabbits and guinea-pigs.

Authors:  Z Gregus; F Varga; A Schmelás
Journal:  Comp Biochem Physiol C       Date:  1985

8.  Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.

Authors:  Miriam G Mooij; Ute I Schwarz; Barbara A E de Koning; J Steven Leeder; Roger Gaedigk; Janneke N Samsom; Edwin Spaans; Johannes B van Goudoever; Dick Tibboel; Richard B Kim; Saskia N de Wildt
Journal:  Drug Metab Dispos       Date:  2014-05-14       Impact factor: 3.922

9.  RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice.

Authors:  Lai Peng; Julia Y Cui; Byunggil Yoo; Sumedha S Gunewardena; Hong Lu; Curtis D Klaassen; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2013-09-30       Impact factor: 3.922

Review 10.  Children versus adults: pharmacokinetic and adverse-effect differences.

Authors:  Gail D Anderson
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

View more
  11 in total

1.  Consequences of Phenytoin Exposure on Hepatic Cytochrome P450 Expression during Postnatal Liver Maturation in Mice.

Authors:  Stephanie C Piekos; Liming Chen; Pengcheng Wang; Jian Shi; Sharon Yaqoob; Hao-Jie Zhu; Xiaochao Ma; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2018-06-08       Impact factor: 3.922

2.  High-Fat Diet Feeding Alters Expression of Hepatic Drug-Metabolizing Enzymes in Mice.

Authors:  Miaoran Ning; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2017-04-25       Impact factor: 3.922

3.  Editor's Highlight: Neonatal Activation of the Xenobiotic-Sensors PXR and CAR Results in Acute and Persistent Down-regulation of PPARα-Signaling in Mouse Liver.

Authors:  Cindy Yanfei Li; Sunny Lihua Cheng; Theo K Bammler; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2016-07-13       Impact factor: 4.849

4.  Perfluorinated Carboxylic Acids with Increasing Carbon Chain Lengths Upregulate Amino Acid Transporters and Modulate Compensatory Response of Xenobiotic Transporters in HepaRG Cells.

Authors:  Joe Jongpyo Lim; Youjun Suh; Elaine M Faustman; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2021-12-02       Impact factor: 3.579

5.  Novel Interactions between Gut Microbiome and Host Drug-Processing Genes Modify the Hepatic Metabolism of the Environmental Chemicals Polybrominated Diphenyl Ethers.

Authors:  Cindy Yanfei Li; Soowan Lee; Sara Cade; Li-Jung Kuo; Irvin R Schultz; Deepak K Bhatt; Bhagwat Prasad; Theo K Bammler; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2017-09-01       Impact factor: 3.922

6.  Population pharmacokinetic analysis of intravenous busulfan: GSTA1 genotype is not a predictive factor of initial dose in Chinese adult patients undergoing hematopoietic stem cell transplantation.

Authors:  Yidan Sun; Jingjing Huang; Chenxia Hao; Ziwei Li; Wu Liang; Weixia Zhang; Bing Chen; Wanhua Yang; Jiong Hu
Journal:  Cancer Chemother Pharmacol       Date:  2019-12-13       Impact factor: 3.333

7.  Characterizing drug-metabolizing enzymes and transporters that are bona fide CAR-target genes in mouse intestine.

Authors:  Shinhee Park; Sunny Lihua Cheng; Julia Yue Cui
Journal:  Acta Pharm Sin B       Date:  2016-08-02       Impact factor: 11.413

8.  R-Flurbiprofen Traps Prostaglandins within Cells by Inhibition of Multidrug Resistance-Associated Protein-4.

Authors:  Ivonne Wobst; Lisa Ebert; Kerstin Birod; Marthe-Susanna Wegner; Marika Hoffmann; Dominique Thomas; Carlo Angioni; Michael J Parnham; Dieter Steinhilber; Irmgard Tegeder; Gerd Geisslinger; Sabine Grösch
Journal:  Int J Mol Sci       Date:  2016-12-30       Impact factor: 5.923

9.  Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.

Authors:  Lianne de Haan; Sarah J van der Lely; Anne-Loes K Warps; Quincy Hofsink; Pim B Olthof; Mark J de Keijzer; Daniël A Lionarons; Lionel Mendes-Dias; Bote G Bruinsma; Korkut Uygun; Hartmut Jaeschke; Geoffrey C Farrell; Narci Teoh; Rowan F van Golen; Tiangang Li; Michal Heger
Journal:  J Clin Transl Res       Date:  2018-02-16

10.  Cancer Stem Cells: Emergent Nature of Tumor Emergency.

Authors:  Yaroslav R Efremov; Anastasia S Proskurina; Ekaterina A Potter; Evgenia V Dolgova; Oksana V Efremova; Oleg S Taranov; Aleksandr A Ostanin; Elena R Chernykh; Nikolay A Kolchanov; Sergey S Bogachev
Journal:  Front Genet       Date:  2018-11-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.